Provencher ballot breakdown: Ted Falk, Conservative
Canada is heading to the polls on April 28 after a snap spring election was called by Prime Minister Mark Carney at the end ...
Vertex Pharmaceuticals price target raised to $420 from $408 at RBC Capital
RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $420 from $408 and keeps a Sector Perform rating on the shares.
Judge throws out lawsuit challenging Colorado’s ability to cap prices on prescription drugs
A federal judge has thrown out Amgen’s lawsuit against the state board empowered to set price ceilings on prescription drugs ...
Demystifying Vertex Pharmaceuticals: Insights From 17 Analyst Reviews
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...
Money Morning4d
It's Not Too Late to Buy These 2 Stocks for the Nasdaq Correction
Vertex Pharmaceuticals (VRTX) is the second stock to buy for the Nasdaq 100 correction. The biotech stock offers stability ...
Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...